These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37862744)

  • 1. Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?
    Rossing P; Frimodt-Møller M; Persson F
    Semin Nephrol; 2023 May; 43(3):151430. PubMed ID: 37862744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel diagnostic and therapeutic procedures in diabetic nephropathy].
    Pont'uch P
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S57-62. PubMed ID: 27124974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing kidney failure in people with diabetes.
    Marshall SM
    Diabet Med; 2014 Nov; 31(11):1280-3. PubMed ID: 24975167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Type 2 diabetes mellitus and chronic kidney disease].
    Ponťuch P
    Vnitr Lek; 2017; 63(3):188-192. PubMed ID: 28379021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in diabetic nephropathy and chronic kidney disease.
    Fliser D; Wanner C
    Nephrol Dial Transplant; 2021 Jun; 36(Suppl 2):10-13. PubMed ID: 34153982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic kidney disease and vascular comorbidities in patients with type 2 diabetes mellitus in a developing country.
    Bentata Y; Chemlal A; Karimi I; El Alaoui F; Haddiya I; Abouqal R
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):1035-43. PubMed ID: 26354588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness is an independent predictor for albuminuria progression among Asians with type 2 diabetes-A prospective cohort study.
    Zhang X; Low S; Sum CF; Tavintharan S; Yeoh LY; Liu J; Li N; Ang K; Lee SB; Tang WE; Lim SC
    J Diabetes Complications; 2017 Jun; 31(6):933-938. PubMed ID: 28392041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing.
    Christofides EA; Desai N
    J Prim Care Community Health; 2021; 12():21501327211003683. PubMed ID: 33749371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tubular biomarkers of kidney damage: potential value in clinical practice.
    Waanders F; Navis G; van Goor H
    Am J Kidney Dis; 2010 May; 55(5):813-6. PubMed ID: 20438985
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit.
    Hill CJ; Cardwell CR; Patterson CC; Maxwell AP; Magee GM; Young RJ; Matthews B; O'Donoghue DJ; Fogarty DG
    Diabet Med; 2014 Apr; 31(4):448-54. PubMed ID: 24102856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
    Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
    Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
    Kobayashi K; Toyoda M; Kimura M; Hatori N; Furuki T; Sakai H; Takihata M; Umezono T; Ito S; Suzuki D; Takeda H; Kanamori A; Degawa H; Yamamoto H; Machimura H; Mokubo A; Chin K; Obana M; Hishiki T; Aoyama K; Nakajima S; Umezawa S; Shimura H; Aoyama T; Sato K; Miyakawa M
    Diab Vasc Dis Res; 2019 Jan; 16(1):103-107. PubMed ID: 30284913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.